Company Encyclopedia
View More
name
Health Catalyst
HCAT.US
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments, Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics.
70.40 B
HCAT.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care TechnologyIndustry
Industry Ranking18/44
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-31.33%E
    • Profit Margin-34.05%E
    • Gross Margin51.02%B
  • Growth ScoreC
    • Revenue YoY4.64%C
    • Net Profit YoY-35.99%D
    • Total Assets YoY-27.79%E
    • Net Assets YoY-6.51%D
  • Cash ScoreD
    • Cash Flow Margin-293.68%D
    • OCF YoY4.64%C
  • Operating ScoreC
    • Turnover0.45C
  • Debt ScoreC
    • Gearing Ratio43.47%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Health Catalyst Inc. Files Initial Statement of Beneficial Ownership for Director and 10% Owner Mathew Paul Arens

    Health Catalyst Inc. filed an initial statement of beneficial ownership with the SEC, naming Mathew Paul Arens as a director and 10% owner. The filing is accessible via EDGAR, the SEC's system. This AI-generated news brief is for informational purposes and not financial advice. Health Catalyst Inc. is responsible for the original content.

    Reuters·
    US
    HCAT
    -1.10%
    Reuters·
    US
    HCAT
    -1.10%

    Officer Landry Surrenders 14,387 Of Health Catalyst Inc [HCAT]

    Officer Landry of Health Catalyst Inc surrendered 14,387 shares at $2.90 each, valued at $41,725, to cover option exercise costs and tax liabilities. This transaction was disclosed in a Form 4 filed with the SEC on December 3, 2025. Landry's ending holdings are 127,425 shares directly.

    Reuters·
    US
    HCAT
    -1.10%
    Reuters·
    US
    HCAT
    -1.10%

    Officer Freeman Surrenders 16,401 Of Health Catalyst Inc [HCAT]

    Officer Kevin Lee Freeman of Health Catalyst Inc surrendered 16,401 shares at $2.90 each, valued at $47,566, to cover option exercise costs and/or tax liabilities. His direct holdings now total 358,686 shares. This transaction was disclosed in a Form 4 filed with the SEC on December 3, 2025.

    Reuters·
    US
    HCAT
    -1.10%
    Reuters·
    US
    HCAT
    -1.10%

    Health Catalyst Appoints Matt Arens to Board as Matthew Kolb Plans Departure

    Health Catalyst Inc. appoints Matt Arens to its board of directors, effective December 1, 2025, as Matthew Kolb plans to depart, not standing for re-election at the 2026 annual meeting.

    Reuters·
    US
    HCAT
    -1.10%
    Reuters·
    US
    HCAT
    -1.10%

    Officer Ross Files To Sell 4,793 Of Health Catalyst Inc [HCAT]

    Officer Ross David of Health Catalyst Inc filed a Form 144 with the SEC to sell 4,793 restricted shares on December 1, 2025, through Morgan Stanley Smith Barney LLC. This filing allows the sale of shares within 90 days.

    Reuters·
    US
    HCAT
    -1.10%
    Reuters·
    US
    HCAT
    -1.10%
    © 2025 Longbridge｜Disclaimer